2005 诺贝尔医学生理学奖


         10月3日，瑞典卡罗林斯卡医学院宣布，把2005年诺贝尔生理学或医学奖授予澳大利亚科学家Barry J. Marshall和J. Robin Warren，以表彰他们发现了导致胃炎和胃溃疡的细菌-幽门螺杆菌。诺贝尔奖委员会在授奖词中说，由于Barry J. Marshall和J. Robin Warren的发现，使得原本慢性的、经常无药可救的胃溃疡变成了只需抗生素和一些其他药物短期就可治愈的疾病。
         在Marshall和Warren发现这种细菌之前，医学界认为正常胃里细菌是不能存活的。1979年根据活组织切片检查结果，Warren发现50%左右的病人的胃腔下半部分附生着许多微小的、弯曲状的细菌。Warren的发现引来了 同行的质疑，但也引起了Marshall的极大兴趣，他们决定联合对取自100个病人的活组织切片进行研究。经过反复试验，Marshall成功地培育出一种当时尚不为人知晓的细菌-后来被命名为幽门螺杆菌。基于试验结果，Marshall和Warren认为，幽门螺杆菌是导致胃炎、十二指肠溃疡或胃溃疡的关键因素。发现这种细菌，使胃炎、十二指肠溃疡或胃溃疡的诊断治疗变得及其简单。目前科学家正在研究幽门螺杆菌与胃癌和一些淋巴肿瘤发病之间的联系。
        CMBI特将两位获奖者背景、相关论文、网络链接资源以及幽门螺杆菌相关的文献等信息汇总于此，以供广大读者了解学习之用。

The Nobel Prize in Physiology or Medicine 2005
"for their discovery of the bacterium Helicobacter pylori and its role in gastritis and peptic ulcer disease"
 
Richard Axel Linda B. Buck
Barry J. Marshall J. Robin Warren
half 1/2 of the prize half 1/2 of the prize
Australia Australia
NHMRC Helicobacter pylori Research Laboratory, QEII Medical Centre; University of Western Australia
Nedlands, Australia 		Perth, Australia
b. 1951 b. 1937
Curriculum Vitae Curriculum Vitae

Barry J. Marshall's page at the University of Western Australia
Barry J. Marshall's web page
Helicobacter pylori Research Laboratory
The Helicobacter Foundatio

About J. Robin Warren from The Australian Institute of Political Science
Helicobacter pylori Research Laboratory
The Helicobacter Foundation
 
Barry J. Marshall
  • Marshall BJ.The Lasker Awards: celebrating scientific discovery. JAMA. 2005 Sep 21;294(11):1420-1.
  • Windsor HM, Abioye-Kuteyi EA, Leber JM, Morrow SD, Bulsara MK, Marshall BJ.Prevalence of Helicobacter pylori in Indigenous Western Australians: comparison between urban and remote rural populations. Med J Aust. 2005 Mar 7;182(5):210-3.
  • Ho GY, Windsor HM, Snowball B, Marshall BJ.Helicobacter pylori is not the cause of sudden infant death syndrome (SIDS). Am J Gastroenterol. 2001 Dec;96(12):3288-94.
  • Samuels AL, Windsor HM, Ho GY, Goodwin LD, Marshall BJ.Culture of Helicobacter pylori from a gastric string may be an alternative to endoscopic biopsy. J Clin Microbiol. 2000 Jun;38(6):2438-9.
  • Windsor HM, Ho GY, Marshall BJ.Successful recovery of H. pylori from rapid urease tests (CLO tests). Am J Gastroenterol. 1999 Nov;94(11):3181-3.
  • Forbes GM, Glaser ME, Cullen DJ, Warren JR, Christiansen KJ, Marshall BJ, Collins BJ.Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up. Lancet. 1994 Jan 29;343(8892):258-60.
  • Marshall BJ, Goodwin CS, Warren JR, Murray R, Blincow ED, Blackbourn SJ, Phillips M, Waters TE, Sanderson CR.Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet. 1988 Dec 24-31;2(8626-8627):1437-42.
  • Goodwin CS, Marshall BJ, Blincow ED, Wilson DH, Blackbourn S, Phillips M.Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies. J Clin Pathol. 1988 Feb;41(2):207-10.
    		•
    J. Robin Warren
  • Warren JR, Noone JT, Smith BJ, Ruffin R, Frith P, van der Zwaag BJ, Beliakov GV, Frankel HK, McElroy HJ. Automated attention flags in chronic disease care planning. Med J Aust. 2001 Sep 17;175(6):308-12.
  • Warren JR. Gastric pathology associated with Helicobacter pylori. Gastroenterol Clin North Am. 2000 Sep;29(3):705-51. Review.
  • Warren JR, Bolton P. Intelligent split menus for data entry: a simulation study in general practice medicine. Proc AMIA Symp. 1999;:450-4.
  • Warren JR, Posey B, Thornton T, Parang P. Can computer autoacquisition of medical information meet the needs of the future? A feasibility study in direct computation of the fine grained electronic medical record. Proc AMIA Symp. 1999;:445-9.
  • Warren JR, Tyerman SP. Webifying a patient interview support application. Med Inform (Lond). 1998 Jan-Mar;23(1):63-74.
  • Forbes GM, Warren JR, Glaser ME, Cullen DJ, Marshall BJ, Collins BJ. Long-term follow-up of gastric histology after Helicobacter pylori eradication. J Gastroenterol Hepatol. 1996 Jul;11(7):670-3.
  • Forbes GM, Glaser ME, Cullen DJ, Warren JR, Christiansen KJ, Marshall BJ, Collins BJ. Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up. Lancet. 1994 Jan 29;343(8892):258-60.
  • Marshall BJ, Goodwin CS, Warren JR, Murray R, Blincow ED, Blackbourn SJ, Phillips M, Waters TE, Sanderson CR. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet. 1988 Dec 24-31;2(8626-8627):1437-42.

    • 幽门螺杆菌相关文献

  • cv-as-Heme Oxygenase-1 Is Expressed in Carotid Atherosclerotic Plaques Infected by Helicobacter pylori and Is More Prevalent in Asymptomatic Subjects
  • ck-cell-Helicobacter pylori, T cells and cytokines-the dangerous liaisons
  • cv-clin-Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects
  • gi-Gastroenterology-Does Helicobacter pylori attack ghrelin-producing cells
  • imm-Autoimmunity-Helicobacter pylori and gastric autoimmunity
  • inf-Expanding the Spectrum of Helicobacter pylori-Associated Diseases
  • Abdominal Imaging-Gastritis from NSAIDS to Helicobacter pylori
  • pediatric-inf-What Is New Related to Helicobacter pylori Infection in Children and Teenagers.
  • imm-Immune subversion by Helicobacter pylori
  • imm-Infectious agents and human immune diseases-Lessons from Helicobacter pylori
  • imm-Innate immunity in health and disease-Innate immune recognition of the extracellular mucosal pathogen, Helicobacter pylori
  • ca-therapy-Clinical Activity of Rituximab in Gastric Marginal Zone Non-Hodgkin's Lymphoma Resistant to or Not Eligible for Anti–Helicobacter Pylori Therapy
  • cv-inf-Eradication of Helicobacter pyloriin clinical situations
  • inf-Host–pathogen interactions-Interaction of Helicobacter pylori with host cells
  • renal disease-peritoneal dialysis-Seroprevalence of Helicobacter pylori in Chinese patients on continuous ambulatory peritoneal dialysis
  • ca-Prevention-Helicobacter pylori and gastric cancer prevention is possible
  • ca-risk-gi-Helicobacter pylori and gastric diseases
  • allerg-The association of hepatitis A and Helicobacter pylori with sensitization to common allergens, asthma and hay fever in a population of young British adults
  • ca-Gene-Molecular biology of gastric cancer-Helicobacter infection and gastric adenocarcinoma-bacterial and host factors responsible for altered growth signaling
  • gi-Influence of gastritis on cyclooxygenase-2 expression before and after eradication of Helicobacter pylori infection
  • gi-reflux disease-The Effect of Helicobacter pylori Eradication on Gastroesophageal Reflux Disease
  • Therapy-Gi-Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment
  • cv-Atherogenesis in perspective-CagA-positive Helicobacter pylori strains may influence the natural history of atherosclerotic stroke
  • gi-Factors predicting progression of gastric intestinal metaplasia results of a randomised trial on Helicobacter pylori eradication.
  • gi-Helicobacter pylori infection-Challenge model for Helicobacter pylori infection in human volunteers.
  • gi-Helicobacter pylori infection-Decreased Helicobacter pylori associated gastric carcinogenesis in mice lacking inducible nitric oxide synthase.
  • gi-Symptomatic Response to Helicobacter Pylori Eradication in Children With Recurrent Abdominal Pain Double Blind Randomized Placebo-controlled Trial.
  • gi-Helicobacter pylori infection-Helicobacter pylori Eradication to Prevent Gastric Cancer in a High-Risk Region of China A Randomized Controlled Trial
  • gi-Natural Antibiotic Function of a Human Gastric Mucin Against Helicobacter pylori Infection
  • cv-inf-Association Between Cerebral Ischemia and Cytotoxin-Associated Gene-A–Helicobacter pylori
  • gi-Deoxyribonucleic acid-based diagnostic techniques to detect Helicobacter pylori
  • gi-Helicobacter pylori-Why are eradication results so variable
  • gi-physiol-A model for the study of Helicobacter pylori interaction with human gastric acid secretion
  • ca-risk-Helicobacter pylori Infection and Gastric Atrophy
  • cell-Apoptosis from Signaling Pathways to Therapeutic Tools-13-Infection-NF-B and Bcl-2 in Helicobacter pylori-Induced Apoptosis in Gastric Epithelial Cells
  • cell-Apoptosis from Signaling Pathways to Therapeutic Tools-2-Signal Transduction-The Effect of p38 Mitogen-Activated Protein Kinase on Mucin Gene Expression and Apoptosis in Helicobacter pylori-Infected Gastric
  • ca-epidemiol-Is Helicobacter pylori Infection a Necessary Condition for Noncardia Gastric Cancer
  • gi-CsrA in the highly adapted human gastric pathogen Helicobacter pylori
  • inf-Helicobacter pylori persistence-biology and disease---
  • therapy-gi-Helicobacter pylori eradication and antisecretory therapy
  • therapy-gi-Impact of Helicobacter pylori on society
  • ca-gi-Helicobacter pylori Eradication to Prevent Gastric Cancer in a High-Risk Region of China
  • ca-gi-Helicobacter pylori-induced epithelial cell signalling in gastric carcinogenesis
  • cv-inf-Immunohistochemical testing for Helicobacter pylori infection in ascending aortic aneurysms
  • proteome-Analysis of Automatically Generated Peptide Mass Fingerprints of Cellular Proteins and Antigens from Helicobacter pylori 26695 Separated by Two-dimensional Electrophoresis
  • Gi-Etiology And Therapy Of Helicobacter Pylori-Associated Gastric Lymphomas
  • Gi-Molecular Mechanism Of Action Of Major Helicobacter Pylori Virulence Factors
  • cv-hp-Eradication of Helicobacter pylori and use of antisecretory drugs population based cohort study
  • cv-hp-Helicobacter pylori Vacuolating Cytotoxin Inhibits T Lymphocyte Activation
  • imm-Protective immunity against Helicobacter is characterized by a unique transcriptional signature
  • Intern Med-Helicobacter Pylori-When Is Treatment Now Indicated
  • Medicine-Molecular Diagnostics-Determining Antibiotic Resistance In Helicobacter Pylori
  • medicine-Treatment of Helicobacter gastritis with IL-4 requires somatostatin
  • Physiol-Gi-Gastric Biology Of Helicobacter Pylori
  • Therapy-Gi-Inf-Alternative And Rescue Treatment Regimens For Helicobacter Pylori Eradication
  • Therapy-Gi-Inf-Eradication Of Helicobacter Pylori-Current Perspectives
  • Therapy-Tagent-Inf-Potential Of Fumarate Reductase As-Novel Therapeutic Target In Helicobacter Pylori
  • Gi-Determinants Of Non-Toxicity In The Gastric Pathogen Helicobacter Pylori
  • Gi-Involvement Of Syntaxin 7 In Human Gastric Epithelial Cell Vacuolation Induced By The Helicobacter Pylori-Produced Cytotoxin Vaca
  • ca-genetics-The complete genome sequence of the carcinogenic bacterium Helicobacter hepaticus
  • cv-inf-Protein-tyrosine Phosphatase , RPTP, Is a Helicobacter pylori VacA Receptor
  • gi-Apoptosis of Gastric Lymphocytes in Helicobacter pylori-Infected Rhesus Macaques
  • inf-Helicobacter pylori-an invading microorganism
  • inf-Microbial Genetics-VGenome-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
  • cv-inf-Detection of Chlamydia pneumoniae but not of Helicobacter pylori in symptomatic atherosclerotic carotids associated with enhanced serum antibodies, inflammation and apoptosis rate
  • cv-os-Helicobacter pylori-Induced oxidative stress and DNA Damage in a Primary Culture of Gastric Mucosal
  • ca-prevention of Helicobacter pylori-associated Gastric Carcinogenesis
  • cv-os-Molecular and cellular mechanisms involved in Helicobacter pylori-induced inflammation and oxidative stress
  • gi-Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease
  • inf-The impact of parietal cells on Helicobacter pylori tropism and host pathology
  • cv-inf-Increased Risk of Atherosclerosis Is Confined to CagA-Positive Helicobacter pylori Strains
  • Proteome-Analysis of Secreted Proteins of the Gastric Pathogen Helicobacter pylori
  • medicine-Evidence-Based-Helicobacter pylori eradication improved dyspepsia symptoms
  • medicine-Evidence-Based-Noninvasive Helicobacter pylori testing was as effective as endoscopy for managing dyspepsia
  • pathol-Effect of Helicobacter pylori on apoptosis and apoptosis related genes in gastric cancer cells
  • pathol-Helicobacter pylori genotyping in gastric adenocarcinoma and MALT lymphoma by multiplex PCR analyses
  • gi-Helicobacter pylori and reflux disease
  • ca-Helicobacter pylori-resurrection of the cancer link
  • physiol-THE GASTRIC BIOLOGY OFHELICOBACTER PYLORI
  • imm-autoimmu-Chronic Gastritis Patients to Helicobacter pylori-Mediated Autoimmunity
  • gi-The non-H pylori helicobacters-their expanding role in gastrointestinal and systemic diseases
  • gi-The importance of interleukin 1[beta] in Helicobacter pylori associated disease
  • pathol-Inflammation-Molecular and cellular mechanisms involved in Helicobacter pylori-induced inflammation and oxidative stress
  • pathol-Analysis of apoptotic and antiapoptotic signalling pathways induced by Helicobacter pylori
  • medicine-Helicobacter pylori Infection
  • therapy-New strategies for the prevention and treatment of Helicobacter pylori infection
  • therapy-Alternative and rescue treatment regimens for Helicobacter pylori eradication
  • therapy-Eradication of Helicobacter pylori-current perspectives
  • cv-inf-Chlamydia pneumoniae, Helicobacter pylori and cytomegalovirus infections and the risk of peripheral arterial disease
  • cv-inf-Lack of association of Helicobacter pylori infection with coronary artery disease and frequency of acute myocardial infarction or death
  • gi-Helicobacter pylori and gut hormones
  • surg-Helicobacter pylori and the gastroduodenal mucosa
  • gi-Helicobacter pylori infection-Current concepts in the management of Helicobacter pylori infection–The Maastricht 2-2000 Consensus Report
  • gi-Helicobacter pylori infection-Helicobacter pylori and nonulcer dyspepsia
  • cv-inf-Effect of Treatment for Chlamydia pneumoniae and Helicobacter pylori on Markers of Inflammation and Cardiac Events in Patients With Acute Coronary Syndromes
  • gi-Helicobacter pylori infection-Introduction (N .B.VAKIL)
  • gi-After gastritis-an imaginary journey into a Helicobacter-free world
  • gi-Helicobacter pylori infection-Helicobacter pylori infection from pathogenesis to treatment-– a critical reappraisal
  • gi-Helicobacter pylori infection-Helicobacter pylori and clinical risks-focus on gastro-oesophageal reflux disease
  • gi-Helicobacter pylori infection-Helicobacter pylori and uninvestigated dyspepsia
  • gi-Helicobacter pylori infection-Natural history and epidemiology of Helicobacter pylori infection
  • gi-Helicobacter pylori infection-Esomeprazole in the treatment of Helicobacter pylori
  • gi-Helicobacter pylori infection-Helicobacter pylori infection in peptic ulcer haemorrhage
  • drug-Antimicrob-Three-Dimensional Quantitative Structure-Activity Relationship and Comparative Molecular Field Analysis of Dipeptide Hydroxamic Acid Helicobacter pylori Urease Inhibitors
  • gi-Helicobacter pylori infection-Diagnosis of Helicobacter pylori infection
  • gi-Helicobacter pylori infection-Treatment of Helicobacter pylori infection and factors influencing eradication
  • gi-Helicobacter pylori infection-Helicobacter pylori and gastric adenocarcinoma
  • gi-Helicobacter pylori infection-Gastro-oesophageal reflux disease and Helicobacter pylori infection
  • gi-Helicobacter species and hepatobiliary diseases
  • gi-Helicobacter pylori infection-Rabeprazole-based therapy in Helicobacter pylori eradication
  • gi-Helicobacter pylori infection-Gastric cancer and Helicobacter pylori
  • proteome-Immunoproteomics of Helicobacter pylori infection and relation to gastric disease
  • cv-inf-Cytotoxin-Associated Gene-A–Positive Helicobacter pylori Strains Are Associated With Atherosclerotic Stroke
  • cv-inf-Cross-Reactivity of Anti-CagA Antibodies With Vascular Wall Antigens-Possible Pathogenic Link Between Helicobacter pylori Infection and Atherosclerosis
  • cv-risk-The non-H pylori helicobacters-their expanding role in gastrointestinal and systemic diseases
  • Influence of Helicobacter pylori Infection During Atherogenesis In Vivo in Mice
  • TGF-Association between CagA+ Helicobacter pylori infection and p53, bax and transforming growth factor-RII gene mutations in gastric cancer patients
  • surg-Helicobacter pylori and the gastroduodenal mucosa
  • biotech-vaccine-Helicobacter pylori vaccine strategies_triggering a gut reaction
  • drug-antibiotic-Resistance of Helicobacter pylori to antibiotics and its impact on treatment options
  • gi-Helicobacter pylori and nonsteroidal anti-inflammatory drugs
  • gi-pathogenesis of Helicobacter pylori-induced gastric inflammation
  • gi-THE DISEASE SPECTRUM OF HELICOBACTER PYLORI-The Immunopathogenesis of Gastroduodenal Ulcer and Gastric Cancer
  • gi-Alternative antibacterial agents for Helicobacter pylori eradication
  • internal medicine-The urea breath test for Helicobacter pylori infection-taking the wind out of the sails of endoscopy
  • drug-antibiotic-Management of Helicobacter pylori infection
  • gi-processpaidAlternative antibacterial agents for Helicobacter pylori eradication
  • internal medicine-Helicobacter pylori-related diseases
  • internal medicine-Evidence for infection with Helicobacter pylori in patients with acute myocardial infarction
  • Pediatric-Is Helicobacter pylori Infection in Childhood a Risk Factor for Gastric Cancer
  • Pediatric-Helicobacter pylori infection in children
  • Association Between Infection With Helicobacter pylori and Chlamydia pneumoniae and Risk of Ischemic Stroke Subtypes
  • Proteome- analysis of the common human pathogen Helicobacter pylori
  • mp-A systematic review of Helicobacter pylori eradication treatment schedules in children
  • mp-Helicobacter pylori- where are we and where are we going
  • mp-Treatment of Helicobacter pylori
  • mp-Non-steroidal anti-inflammatory drugs and Helicobacter pylori
  • mp-Is Helicobacter pylori status relevant in the management of GORD
  • mp-The control of gastric acid and Helicobacter pylori eradication
  • ANTIBODY -Progress in vaccination against Helicobacter pylori
  • mp-Invasive and non-invasive tests for Helicobacter pylori infection
  • mp-RECENT PROGRESS IN ENDOSCOPY-BASED DIAGNOSIS OF HELICOBACTER PYLORI INFECTION
  • mp-clinical influence of Helicobacter pylori in gastro-oesophageal reflux disease
  • mp-Have we found the source of Helicobacter pylori
  • mp- nitroimidazole resistance in Helicobacter pylori
  • mp-Helicobacter pylori vaccines-the current status
  • mp-Helicobacter pylori and gastric cancer
  • mp-Treatment of Helicobacter pylori infection
  • Helicobacter pylori heat shock protein 60 and risk of coronary heart disease: a case control study with focus on markers of systemic inflammation and lipids
  • inf-Helicobacter pylori genetic diversity and risk of human disease
  • Helicobacter pylori genetic diversity and risk of human disease
  • Current Infection With Helicobacter pylori, but Not Seropositivity to Chlamydia pneumoniae or Cytomegalovirus, Is Associated With an Atherogenic, Modified Lipid Profile
  • Current Infection With Helicobacter pylori, but Not Seropositivity to Chlamydia pneumoniae or Cytomegalovirus, Is Associated With an Atherogenic, Modified Lipid Profile
  • Association of elevation of anti-helicobacter pylori antibody with myocardial ischemic events in coronary artery disease
  • imm-THE DESIGN OF VACCINES AGAINST HELICOBACTER PYLORI AND THEIR DEVELOPMENT
  • inf-Pathogenesis and host response in Helicobacter infections
  • proteome--sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
  • proteome-The protein-protein interaction map of Helicobacter pylori
  • Detection of Helicobacter pylori in Human Carotid Atherosclerotic Plaques
  • protein--protein interaction map of Helicobacter pylori
  • A whole-genome microarray reveals genetic diversity among Helicobacter pylori
  • Analysis of the genetic diversity of Helicobacter pylori- the tale of two genomes
  • Further development of the Helicobacter pylori mouse vaccination model
  • Helicobacter pylori seroprevalence in cirrhotic patients with hepatitis B virus infection
  • Animal models of Helicobacter infection
  • Liver cirrhosis and peptic ulcer disease; a correlation with Helicobacter pylori
  • Prior Cytomegalovirus, Chlamydia pneumoniae or Helicobacter pylori infection and the risk of restenosis after percutaneous transluminal coronary angioplasty
  • Helicobacter pylori and Coronary Heart Disease in Middle-Aged Men
  • Treatment of Helicobacter pylori infection
  • helicobacter-pylori
  • helicobacter-pylori-cancer
  • helicobacter pylori
  • helicobacter pylori-non-ulcer dis
  • helicobacter pylori-cancer
    		•
    Last Modified: 2005-10-04